Genocea Biosciences (GNCA) Misses Q3 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. UNH
7. CVS
8. SBUX
9. AXP
10. ZETA

Go back to Genocea Biosciences (GNCA) Misses Q3 EPS by 2c

Genocea Provides Third Quarter 2020 Corporate Update

October 29, 2020 7:01 AM EDT

Initiated GEN-011 Phase1/2a clinical trial

Presented positive follow-up GEN-009 Part B data at ESMO Virtual Congress 2020 demonstrating potential added benefit to PD-1 inhibitor therapy

Closed financing with net proceeds of $74.5 million

Upcoming presentations at SITC 2020 Virtual Conference on GEN-009, InhibigensTM and GEN-011

Conference call today at 8:30 a.m. EDT

CAMBRIDGE, Mass., Oct. 29, 2020 (GLOBE NEWSWIRE) --... More